The University of Chicago Header Logo

Connection

Daniel Wilson to Mineralocorticoid Receptor Antagonists

Back to Details
This is a "connection" page, showing publications Daniel Wilson has written about Mineralocorticoid Receptor Antagonists.
Daniel Wilson
Connection Strength
0.188
Mineralocorticoid Receptor Antagonists
  1. Finerenone: a mineralocorticoid receptor antagonist for the treatment of chronic kidney disease associated with type 2 diabetes. Expert Rev Clin Pharmacol. 2022 May; 15(5):501-513.
    View in: PubMed
    Score: 0.188
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.